{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:03Z","timestamp":1772119503801,"version":"3.50.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870655"],"award-info":[{"award-number":["31870655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan\u00a0Science\u00a0and\u00a0Technology\u00a0Program","award":["2019YFH0054"],"award-info":[{"award-number":["2019YFH0054"]}]},{"name":"Project of Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department","award":["10Y202104"],"award-info":[{"award-number":["10Y202104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00894-023-05509-4","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T15:02:52Z","timestamp":1679670172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants"],"prefix":"10.1007","volume":"29","author":[{"given":"Yan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"issue":"1","key":"5509_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"F Li","year":"2016","unstructured":"Li F (2016) Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol 3(1):237\u2013261. https:\/\/doi.org\/10.1146\/annurev-virology-110615-042301","journal-title":"Annu Rev Virol"},{"issue":"9393","key":"5509_CR2","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1016\/s0140-6736(03)14630-2","volume":"362","author":"NS Zhong","year":"2003","unstructured":"Zhong NS, Zheng BJ, Li YM et al (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003. Lancet 362(9393):0\u20131358. https:\/\/doi.org\/10.1016\/s0140-6736(03)14630-2","journal-title":"Lancet"},{"issue":"8","key":"5509_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E De Wit","year":"2016","unstructured":"De Wit E, van Doremalen N, Falzarano D et al (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14(8):523\u2013534. https:\/\/doi.org\/10.1038\/nrmicro.2016.81","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"5509_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","volume":"100","author":"F Li","year":"2013","unstructured":"Li F (2013) Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res 100(1):246\u2013254. https:\/\/doi.org\/10.1016\/j.antiviral.2013.08.014","journal-title":"Antiviral Res"},{"issue":"19","key":"5509_CR5","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, Van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367(19):1814. https:\/\/doi.org\/10.1056\/NEJMoa1211721","journal-title":"N Engl J Med"},{"key":"5509_CR6","doi-asserted-by":"publisher","unstructured":"MD Shin, Shukla S, Chung YH, et al (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 15(8). https:\/\/doi.org\/10.1038\/s41565-020-0737-y.","DOI":"10.1038\/s41565-020-0737-y"},{"issue":"2","key":"5509_CR7","first-page":"174","volume":"28","author":"AA Rabaan","year":"2020","unstructured":"Rabaan AA, Al-Ahmed SH, Haque S et al (2020) SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Infez Med 28(2):174\u2013184","journal-title":"Infez Med"},{"key":"5509_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.17179\/excli2020-1167","volume":"19","author":"JT Ortega","year":"2020","unstructured":"Ortega JT, Serrano ML, Pujol FH, Rangel HR (2020) Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J 19:410\u2013417. https:\/\/doi.org\/10.17179\/excli2020-1167","journal-title":"EXCLI J"},{"issue":"1","key":"5509_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14744\/ejmo.2020.12220","volume":"4","author":"A Sahin","year":"2020","unstructured":"Sahin A, Erdogan A, MutluAgaoglu P et al (2020) novel coronavirus (COVID-19) outbreak: a review of the current literature. Eurasian J Med Oncol 4(1):1\u20137. https:\/\/doi.org\/10.14744\/ejmo.2020.12220","journal-title":"Eurasian J Med Oncol"},{"issue":"6485","key":"5509_CR10","doi-asserted-by":"publisher","first-page":"eabb2762","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y et al (2020) Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Sci 367(6485):eabb2762. https:\/\/doi.org\/10.1126\/science.abb2762","journal-title":"Sci"},{"key":"5509_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","volume":"105","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA, Veesler D (2019) Structural insights into coronavirus entry. Adv Virus Res 105:93\u2013116. https:\/\/doi.org\/10.1016\/bs.aivir.2019.08.002","journal-title":"Adv Virus Res"},{"key":"5509_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. NAT MICROBIOL 5:562\u2013569. https:\/\/doi.org\/10.1038\/s41564-020-0688-y","journal-title":"NAT MICROBIOL"},{"key":"5509_CR13","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Cold Spring Harbor Lab 367:1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Cold Spring Harbor Lab"},{"issue":"2","key":"5509_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA et al (2020) Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181(2):281\u2013292. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058","journal-title":"Cell"},{"issue":"2","key":"5509_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"7","key":"5509_CR16","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R et al (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):e00127-e220. https:\/\/doi.org\/10.1128\/JVI.00127-20","journal-title":"J Virol"},{"key":"5509_CR17","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41557-021-00758-3","volume":"13","author":"TE Sztain","year":"2021","unstructured":"Sztain TE, Ahn SH, Bogetti AT et al (2021) A glycan gate controls opening of the SARS-CoV-2 spike protein. Nat Chem 13:963\u2013968","journal-title":"Nat Chem"},{"issue":"7798","key":"5509_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2951-z","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2951-z","journal-title":"Nature"},{"issue":"3","key":"5509_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","volume":"183","author":"H Yao","year":"2020","unstructured":"Yao H, Song Y, Chen Y et al (2020) Molecular architecture of the SARS-CoV-2 virus. Cell 183(3):730\u2013738. https:\/\/doi.org\/10.1016\/j.cell.2020.09.018","journal-title":"Cell"},{"issue":"14","key":"5509_CR20","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 106(14):5871\u20135876. https:\/\/doi.org\/10.1073\/pnas.0809524106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"5509_CR21","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1021\/acs.jpclett.0c01698","volume":"11","author":"N Vankadari","year":"2020","unstructured":"Vankadari N (2020) Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence. J Phys Chem Lett 11(16):6655\u20136663. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01698","journal-title":"J Phys Chem Lett"},{"issue":"6511","key":"5509_CR22","doi-asserted-by":"publisher","first-page":"eabd4251","DOI":"10.1126\/science.abd4251","volume":"369","author":"Y Cai","year":"2020","unstructured":"Cai Y, Zhang J, Xiao T et al (2020) Distinct conformational states of SARS-CoV-2 spike protein. Sci 369(6511):eabd4251. https:\/\/doi.org\/10.1126\/science.abd4251","journal-title":"Sci"},{"issue":"6","key":"5509_CR23","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2018.02.054","volume":"172","author":"FA Rey","year":"2018","unstructured":"Rey FA, Lok SM (2018) Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell 172(6):1319\u20131334. https:\/\/doi.org\/10.1016\/j.cell.2018.02.054","journal-title":"Cell"},{"key":"5509_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai L, Gao GF (2021) Viral targets for vaccines against COVID-19. Nat Rev Immunol 21:73\u201382. https:\/\/doi.org\/10.1038\/s41577-020-00480-0","journal-title":"Nat Rev Immunol"},{"key":"5509_CR25","doi-asserted-by":"publisher","first-page":"e202000786","DOI":"10.1101\/2020.04.15.042085","volume":"3","author":"D Bestle","year":"2020","unstructured":"Bestle D, Heindl MR, Limburg H et al (2020) TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets. BioRxiv. 3:e202000786. https:\/\/doi.org\/10.1101\/2020.04.15.042085","journal-title":"BioRxiv."},{"key":"5509_CR26","unstructured":"COVID-19 vaccine tracker: vaccine landscape. https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/_w_ec54614e\/#tab-1609-6 (accessed June 25, 2021)."},{"key":"5509_CR27","unstructured":"COVID-19 vaccine tracker: clinical trials database. https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/_w_ec54614e\/#tab-1609-2 (accessed June 25, 2021)."},{"issue":"7","key":"5509_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMc2113090","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C et al (2021) Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 385(7):585\u2013594. https:\/\/doi.org\/10.1056\/NEJMc2113090","journal-title":"N Engl J Med."},{"issue":"10278","key":"5509_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(21)00370-6","volume":"397","author":"A Fontanet","year":"2021","unstructured":"Fontanet A, Autran B, Lina B et al (2021) SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 397(10278):952\u2013954. https:\/\/doi.org\/10.1016\/S0140-6736(21)00370-6","journal-title":"Lancet"},{"key":"5509_CR30","unstructured":"Our world in data: coronavirus (COVID-19) vaccinations: https:\/\/ourworldindata.org\/covid-vaccinations (accessed June 25, 2021)."},{"issue":"11","key":"5509_CR31","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/s41591-021-01560-x","volume":"27","author":"JA Juno","year":"2021","unstructured":"Juno JA, Wheatley AK (2021) Boosting immunity to COVID-19 vaccines. Nat Med 27(11):1874\u20131875. https:\/\/doi.org\/10.1038\/s41591-021-01560-x","journal-title":"Nat Med"},{"issue":"11","key":"5509_CR32","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/CKJ\/SFAB152","volume":"14","author":"M Dekervel","year":"2021","unstructured":"Dekervel M, Henry N, Torreggiani M et al (2021) Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis. Oxford University Press (OUP) 14(11):2349\u20132355. https:\/\/doi.org\/10.1093\/CKJ\/SFAB152","journal-title":"Oxford University Press (OUP)"},{"issue":"593","key":"5509_CR33","doi-asserted-by":"publisher","first-page":"eab1906","DOI":"10.1126\/scitranslmed.abf1906","volume":"13","author":"BE Jones","year":"2021","unstructured":"Jones BE, Brown-Augsburger PL, Corbett KS et al (2021) The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med 13(593):eab1906. https:\/\/doi.org\/10.1126\/scitranslmed.abf1906","journal-title":"Sci Transl Med"},{"key":"5509_CR34","unstructured":"Anon, 2020. An EUA for casirivimab and imdevimab for COVID-19. Med. Lett. Drugs Ther.62 (1614), 201\u2013202. https:\/\/publons.com\/wos-op\/search\/?search=An+EUA+for+Casirivimab+and+Imdevimab+for+COVID-19 (accessed July 13, 2021)."},{"key":"5509_CR35","unstructured":"Anon, 2021. An EUA for sotrovimab for treatment of COVID-19. Med. Lett. Drugs Ther.63 (1627), 97\u201398. https:\/\/publons.com\/wos-op\/search\/?search=An+EUA+for+sotrovimab+for+treatment+of+COVID-19 (accessed July 13, 2021)"},{"key":"5509_CR36","doi-asserted-by":"publisher","unstructured":"Drodal S, Rosik J, Lechowicz K, et al. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist. Update. 2021(January):100794. https:\/\/doi.org\/10.1016\/j.drup.2021.100794.","DOI":"10.1016\/j.drup.2021.100794"},{"issue":"15","key":"5509_CR37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2146\/ajhp070449","volume":"65","author":"A Sebba","year":"2008","unstructured":"Sebba A (2008) Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health-Syst Pharm 65(15):1413\u20131418. https:\/\/doi.org\/10.2146\/ajhp070449","journal-title":"Am J Health-Syst Pharm"},{"key":"5509_CR38","doi-asserted-by":"publisher","unstructured":"Stebbing J, Krishnan V, Bono SD, Ottaviani S, & Corbellino M (2020) Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol. Med. 12 (8). https:\/\/doi.org\/10.15252\/emmm.202012697","DOI":"10.15252\/emmm.202012697"},{"key":"5509_CR39","unstructured":"Cov-lineages: VOC reports. https:\/\/cov-lineages.org\/index.html#global_reports. (accessed December 9, 2021)"},{"issue":"4","key":"5509_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cell.2022.01.001","volume":"185","author":"P Han","year":"2022","unstructured":"Han P, Li L, Liu S et al (2022) Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell 185(4):630\u2013640. https:\/\/doi.org\/10.1016\/j.cell.2022.01.001","journal-title":"Cell"},{"issue":"1","key":"5509_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","volume":"22","author":"A Kat","year":"2022","unstructured":"Kat A, Tn F, Az A et al (2022) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infect. Dis. 22(1):35\u201342. https:\/\/doi.org\/10.1016\/S1473-3099(21)00475-8","journal-title":"Lancet Infect. Dis."},{"issue":"25","key":"5509_CR42","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMC2114706","volume":"385","author":"K Uriu","year":"2021","unstructured":"Uriu K, Kimura I, Shirakawa K et al (2021) Neutralization of the SARS-CoV-2 mu variant by convalescent and vaccine serum. N Engl J Med 385(25):2397\u20132399. https:\/\/doi.org\/10.1056\/NEJMC2114706","journal-title":"N Engl J Med"},{"issue":"6","key":"5509_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.24272\/j.issn.2095-8137.2021.343","volume":"42","author":"X Xie","year":"2021","unstructured":"Xie X, Han JB, Ma G et al (2021) Emerging SARS-CoV-2 B.1.621\/mu variant is prominently resistant to inactivated vaccine-elicited antibodies. Zool Res 42(6):789\u2013791. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2021.343","journal-title":"Zool Res"},{"key":"5509_CR44","doi-asserted-by":"crossref","unstructured":"Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern, (n.d.). https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern (accessed December 9, 2021).","DOI":"10.47799\/pimr.0903.01"},{"key":"5509_CR45","unstructured":"Science brief: omicron (B.1.1.529) variant | CDC, (n.d.). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/scientific-brief-omicron-variant.html (accessed December 9, 2021)."},{"key":"5509_CR46","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A et al (2021) Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 27:1205\u20131211. https:\/\/doi.org\/10.1038\/s41591-021-01377-8","journal-title":"Nat Med"},{"key":"5509_CR47","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","volume":"602","author":"E Cameroni","year":"2021","unstructured":"Cameroni E, Bowen JE, Rosen LE et al (2021) Broadly neutralizing antibodies overcome SARS-CoV-2 omicron antigenic shift. Nature 602:664\u2013670. https:\/\/doi.org\/10.1038\/s41586-021-04386-2","journal-title":"Nature"},{"issue":"1","key":"5509_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43556-022-00074-3","volume":"3","author":"D Guo","year":"2022","unstructured":"Guo D, Duan H, Cheng Y et al (2022) Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies. Mol Biomed 3(1):1\u201318. https:\/\/doi.org\/10.1186\/s43556-022-00074-3","journal-title":"Mol Biomed"},{"issue":"1","key":"5509_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-00903-5","volume":"7","author":"X Du","year":"2022","unstructured":"Du X, Tang H, Gao L et al (2022) Omicron adopts a different strategy from delta and other variants to adapt to host. Signal Transduct Target Ther 7(1):1\u20133. https:\/\/doi.org\/10.1038\/s41392-022-00903-5","journal-title":"Signal Transduct Target Ther"},{"key":"5509_CR50","doi-asserted-by":"publisher","unstructured":"Artese A, Svicher V, Costa G, et al (2020) Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist. Update. 53. https:\/\/doi.org\/10.1016\/j.drup.2020.100721.","DOI":"10.1016\/j.drup.2020.100721"},{"key":"5509_CR51","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.drup.2020.100733","volume":"53","author":"JD Twomey","year":"2020","unstructured":"Twomey JD, Luo S, Dean AQ et al (2020) COVID-19 update: the race to therapeutic development. Drug Resist Update. 53:100733. https:\/\/doi.org\/10.1016\/j.drup.2020.100733","journal-title":"Drug Resist Update."},{"key":"5509_CR52","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"W1","author":"W Andrew","year":"2018","unstructured":"Andrew W, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res W1:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"5509_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1101\/2020.09.18.301952","volume":"28","author":"T Xiao","year":"2021","unstructured":"Xiao T, Lu J, Zhang J et al (2021) A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitro. Nat Struct Mol Biol 28:202\u2013209. https:\/\/doi.org\/10.1101\/2020.09.18.301952","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"5509_CR54","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/wcms.1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan S, Chan H, Hu Z (2017) Using PyMOL as a platform for computational drug design. Wiley Interdiscip Rev Comput Mol Sci 7(2):e1298. https:\/\/doi.org\/10.1002\/wcms.1298","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"5509_CR55","doi-asserted-by":"publisher","unstructured":"G. C P, van, Zundert J, P. G. L. M, et al (2016) The HADDOCK2.4 web server: user-friendly integrative modeling of biomolecular complexes. J. Mol. Biol. 2016; 428:720\u2013725. https:\/\/doi.org\/10.1016\/j.jmb.2015.09.014.","DOI":"10.1016\/j.jmb.2015.09.014"},{"key":"5509_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/2021.06.23.449282","volume":"1","author":"BJ Fraser","year":"2021","unstructured":"Fraser BJ, Beldar S, Seitova A et al (2021) Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation. BioRxiv 1:1\u201319. https:\/\/doi.org\/10.1101\/2021.06.23.449282","journal-title":"BioRxiv"},{"issue":"4","key":"5509_CR57","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41586-020-2852-1","volume":"183","author":"CO Barnes","year":"2020","unstructured":"Barnes CO, Jette CA, Abernathy ME et al (2020) SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 183(4):1024\u20131042. https:\/\/doi.org\/10.1038\/s41586-020-2852-1","journal-title":"Nature"},{"issue":"9","key":"5509_CR58","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"5509_CR59","doi-asserted-by":"publisher","unstructured":"Case, DA, Cerutti DS, Cheatham TE, Darden TA, & Kollman PA. Amber 2017, University of California, San Francisco. https:\/\/doi.org\/10.13140\/RG.2.2.36172.41606.","DOI":"10.13140\/RG.2.2.36172.41606"},{"issue":"2","key":"5509_CR60","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"issue":"8","key":"5509_CR61","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto S, Kollman PA (1992) Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13(8):952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805","journal-title":"J Comput Chem"},{"issue":"1","key":"5509_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"A Humphrey Dalke","year":"1996","unstructured":"Humphrey Dalke A, Schulten K (1996) VMD-visual molecular dynamics. J Mol Graph 14(1):33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"5509_CR63","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/bip.360291008","volume":"29","author":"J Kottalam","year":"1990","unstructured":"Kottalam J, Case DA (1990) Langevin modes of macromolecules: applications to crambin and DNA hexamers. Biopolymers 29:1409\u20131421. https:\/\/doi.org\/10.1002\/bip.360291008","journal-title":"Biopolymers"},{"issue":"12","key":"5509_CR64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman PA, Massova I, Reyes C et al (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Accounts Chem Res 33(12):889\u2013897. https:\/\/doi.org\/10.1021\/ar000033j","journal-title":"Accounts Chem Res"},{"issue":"2","key":"5509_CR65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0959-440X(00)00197-4","volume":"11","author":"T Simonson","year":"2001","unstructured":"Simonson T (2001) Macromolecular electrostatics: continuum models and their growing pains. Curr Opin Struct Biol 11(2):243\u2013252. https:\/\/doi.org\/10.1016\/S0959-440X(00)00197-4","journal-title":"Curr Opin Struct Biol"},{"issue":"4","key":"5509_CR66","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1039\/C9CP05704H","volume":"22","author":"J Chen","year":"2019","unstructured":"Chen J, Liu X, Zhang S et al (2019) Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses. Phys Chem Chem Phys 22(4):2262\u20132275. https:\/\/doi.org\/10.1039\/C9CP05704H","journal-title":"Phys Chem Chem Phys"},{"issue":"1","key":"5509_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/bioinformatics\/btl529","volume":"23","author":"I Letunic","year":"2007","unstructured":"Letunic I, Bork P (2007) Interactive tree of life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23(1):127\u2013128. https:\/\/doi.org\/10.1093\/bioinformatics\/btl529","journal-title":"Bioinformatics"},{"issue":"5765","key":"5509_CR68","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.1123061","volume":"311","author":"FD Ciccarelli","year":"2006","unstructured":"Ciccarelli FD, Doerks T, von Mering C et al (2006) Toward automatic reconstruction of a highly resolved tree of life. Sci 311(5765):1283\u20131287. https:\/\/doi.org\/10.1126\/science.1123061","journal-title":"Sci"},{"key":"5509_CR69","doi-asserted-by":"publisher","first-page":"e21053","DOI":"10.1371\/journal.pone.0021053","volume":"6","author":"T David","year":"2011","unstructured":"David T, David L et al (2011) Characterization of protein-protein interaction interfaces from a single species. Plos One 6:e21053. https:\/\/doi.org\/10.1371\/journal.pone.0021053","journal-title":"Plos One"},{"issue":"1","key":"5509_CR70","doi-asserted-by":"publisher","first-page":"24035","DOI":"10.1038\/srep24035","volume":"6","author":"C Peri","year":"2016","unstructured":"Peri C, Morra G, Colombo G (2016) Surface energetics and protein-protein interactions: analysis and mechanistic implications. Sci Rep 6(1):24035. https:\/\/doi.org\/10.1038\/srep24035","journal-title":"Sci Rep"},{"issue":"3","key":"5509_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jcc.540160303","volume":"16","author":"F Eisenhaber","year":"1995","unstructured":"Eisenhaber F, Lijnzaad P, Argos P et al (1995) The double cubic lattice method: efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. J Comput Chem 16(3):273\u2013284. https:\/\/doi.org\/10.1002\/jcc.540160303","journal-title":"J Comput Chem"},{"issue":"27","key":"5509_CR72","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1021\/acs.biochem.7b00339","volume":"56","author":"A Stecula","year":"2017","unstructured":"Stecula A, Schlessinger A, Giacomini KM et al (2017) Human concentrative nucleoside transporter 3 (hCNT3, SLC28A3) forms a cyclic homotrimer. Biochem 56(27):3475. https:\/\/doi.org\/10.1021\/acs.biochem.7b00339","journal-title":"Biochem"},{"issue":"3","key":"5509_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3934\/microbiol.2020021","volume":"6","author":"M Hussain","year":"2020","unstructured":"Hussain M, Jabeen N, Amanullah A et al (2020) Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions. AIMS Microbiol 6(3):350\u2013360. https:\/\/doi.org\/10.3934\/microbiol.2020021","journal-title":"AIMS Microbiol"},{"issue":"5","key":"5509_CR74","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1101\/2021.01.10.426120","volume":"29","author":"G Cerutti","year":"2021","unstructured":"Cerutti G, Guo Y, Zhou T et al (2021) Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe 29(5):819\u2013833. https:\/\/doi.org\/10.1101\/2021.01.10.426120","journal-title":"Cell Host Microbe"},{"issue":"6511","key":"5509_CR75","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abd4251","volume":"369","author":"Y Cai","year":"2020","unstructured":"Cai Y, Zhang J, Xiao T, Peng H, Chen B (2020) Distinct conformational states of SARS-CoV-2 spike protein. Sci 369(6511):1586\u20131592. https:\/\/doi.org\/10.1126\/science.abd4251","journal-title":"Sci"},{"issue":"7807","key":"5509_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K et al (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581(7807):221\u2013224. https:\/\/doi.org\/10.1038\/s41586-020-2179-y","journal-title":"Nature"},{"issue":"7","key":"5509_CR77","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2174\/1386207323666201026160500","volume":"24","author":"W Yu","year":"2020","unstructured":"Yu W, Wu X, Ren J et al (2020) Mechanistic insights to the binding of antibody CR3022 against RBD from SARS-CoV and HCoV-19\/SARS-CoV-2: a computational study. Comb Chem High Throughput Screen 24(7):1069\u20131082. https:\/\/doi.org\/10.2174\/1386207323666201026160500","journal-title":"Comb Chem High Throughput Screen"},{"issue":"5","key":"5509_CR78","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.2174\/1386207323666201026160500","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E et al (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res 87(5):E1-9. https:\/\/doi.org\/10.2174\/1386207323666201026160500","journal-title":"Circ Res"},{"key":"5509_CR79","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"M Crackower","year":"2002","unstructured":"Crackower M, Sarao R, Oudit G et al (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822\u2013828. https:\/\/doi.org\/10.1038\/nature00786","journal-title":"Nature"},{"key":"5509_CR80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J et al (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"issue":"3","key":"5509_CR81","doi-asserted-by":"publisher","first-page":"e1008392","DOI":"10.1371\/journal.ppat.1008392","volume":"16","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Liu C et al (2020) Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry. PLoS Pathog 16(3):e1008392. https:\/\/doi.org\/10.1371\/journal.ppat.1008392","journal-title":"PLoS Pathog"},{"issue":"6541","key":"5509_CR82","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.abf2303","volume":"372","author":"J Zhang","year":"2021","unstructured":"Zhang J, Cai Y, Xiao T et al (2021) Structural impact on SARS-CoV-2 spike protein by D614G substitution. Sci 372(6541):525\u2013530. https:\/\/doi.org\/10.1126\/science.abf2303","journal-title":"Sci"},{"issue":"1","key":"5509_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1073\/pnas.2003138117","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B et al (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23(1):3\u201320. https:\/\/doi.org\/10.1073\/pnas.2003138117","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5509_CR84","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao H, Lu L, Zheng P et al (2022) SARS-CoV-2 omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect 11:277\u2013283. https:\/\/doi.org\/10.1080\/22221751.2021.2023329","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"5509_CR85","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/acs.jcim.1c00560","volume":"61","author":"B Jawad","year":"2021","unstructured":"Jawad B, Adhikari P, Podgornik R, Ching WY (2021) Key interacting residues between RBD of SARS-CoV-2 and ACE2 receptor: combination of molecular dynamics simulation and density functional calculation. J Chem Inf Model 61(9):4425\u20134441. https:\/\/doi.org\/10.1021\/acs.jcim.1c00560","journal-title":"J Chem Inf Model"},{"key":"5509_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2021.12.079","volume":"590","author":"A Csl","year":"2021","unstructured":"Csl A, Yy A, Hong CB et al (2021) Mutations on RBD of SARS-CoV-2 omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun 590:34\u201341. https:\/\/doi.org\/10.1016\/j.bbrc.2021.12.079","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5509_CR87","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr TN, Greaney AJ, Hilton SK et al (2020) Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182(5):1295\u20131310. https:\/\/doi.org\/10.1016\/j.cell.2020.08.012","journal-title":"Cell"},{"issue":"11","key":"5509_CR88","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1110\/ps.12901","volume":"10","author":"R Norel","year":"2008","unstructured":"Norel R, Sheinerman F, Petrey D, Honig B (2008) Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis. Protein Sci 10(11):2147\u20132161. https:\/\/doi.org\/10.1110\/ps.12901","journal-title":"Protein Sci"},{"key":"5509_CR89","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.medidd.2021.100086","volume":"10","author":"F Ali","year":"2021","unstructured":"Ali F, Kasry A, Amin M (2021) The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutation. ArXiv 10:100086. https:\/\/doi.org\/10.1016\/j.medidd.2021.100086","journal-title":"ArXiv"},{"key":"5509_CR90","doi-asserted-by":"publisher","unstructured":"Evans J P, Liu S L (2021) Role of host factors in SARS-CoV-2 entry. J Biol Chem. 297(1). https:\/\/doi.org\/10.1016\/j.jbc.2021.100847.","DOI":"10.1016\/j.jbc.2021.100847"},{"key":"5509_CR91","doi-asserted-by":"publisher","unstructured":"Hussain M, Jabeen N, Amanullah A, et al (2021) Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2. BioRxiv. https:\/\/doi.org\/10.1101\/2020.04.21.052639.","DOI":"10.1101\/2020.04.21.052639"},{"key":"5509_CR92","doi-asserted-by":"publisher","first-page":"e117652","DOI":"10.1016\/j.lfs.2020.117652","volume":"252","author":"B Shah","year":"2020","unstructured":"Shah B, Modi P, Sagar SR (2020) In silico studies on therapeutic agents for COVID-19: drug repurposing approach. Life Sci 252:e117652. https:\/\/doi.org\/10.1016\/j.lfs.2020.117652","journal-title":"Life Sci"},{"issue":"34","key":"5509_CR93","doi-asserted-by":"publisher","first-page":"E542","DOI":"10.1073\/pnas.1104829108","volume":"108","author":"D Cardinale","year":"2011","unstructured":"Cardinale D, Guaitoli G, Tondi D et al (2011) Protein\u2013protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase. Proc Natl Acad Sci U S A 108(34):E542\u2013E549. https:\/\/doi.org\/10.1073\/pnas.1104829108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5509_CR94","doi-asserted-by":"publisher","first-page":"e1009246","DOI":"10.1371\/journal.ppat.1009246","volume":"17","author":"G Papa","year":"2021","unstructured":"Papa G, Mallery DL, Albecka A, Welch LG, James LC (2021) Furin cleavage of SARS-CoV-2 spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog 17:e1009246. https:\/\/doi.org\/10.1371\/journal.ppat.1009246","journal-title":"PLoS Pathog"},{"key":"5509_CR95","doi-asserted-by":"publisher","first-page":"e1009212","DOI":"10.1371\/journal.ppat.1009212","volume":"17","author":"T Ou","year":"2021","unstructured":"Ou T, Mou H, Zhang L et al (2021) Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathog 17:e1009212. https:\/\/doi.org\/10.1371\/journal.ppat.1009212","journal-title":"PLoS Pathog"},{"key":"5509_CR96","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","volume":"602","author":"A Saito","year":"2021","unstructured":"Saito A, Irie T, Suzuki R et al (2021) Enhanced fusogenicity and pathogenicity of SARS-CoV-2 delta P681R mutation. Nature 602:300\u2013306. https:\/\/doi.org\/10.1038\/s41586-021-04266-9","journal-title":"Nature"},{"key":"5509_CR97","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","volume":"6","author":"TP Peacock","year":"2021","unstructured":"Peacock TP, Goldhill DH, Zhou J et al (2021) The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol 6:899\u2013909. https:\/\/doi.org\/10.1038\/s41564-021-00908-w","journal-title":"Nat Microbiol"},{"key":"5509_CR98","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/geno.1997.4845","volume":"44","author":"A Paoloni-Giacobino","year":"1997","unstructured":"Paoloni-Giacobino A, Chen H, Peitsch MC et al (1997) Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22. 3. Genomics 44:309\u2013320. https:\/\/doi.org\/10.1006\/geno.1997.4845","journal-title":"Genomics"},{"key":"5509_CR99","doi-asserted-by":"publisher","unstructured":"Koch J, Uckeley Z, Doldan P, et al (2021) TMPRSS2 expression dictates the entry route used by SARS-CoV-2 infect host cells. EMBO J. 40(16). https:\/\/doi.org\/10.15252\/embj.2021107821.","DOI":"10.15252\/embj.2021107821"},{"key":"5509_CR100","doi-asserted-by":"publisher","unstructured":"Gupta R (2022) SARS-CoV-2 omicron spike mediated immune escape and tropism shift. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-1191837\/v.","DOI":"10.21203\/rs.3.rs-1191837\/v"},{"key":"5509_CR101","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng B, Abdullahi A, Ferreira IATM et al (2022) Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity. Nature 603:706\u2013714. https:\/\/doi.org\/10.1038\/s41586-022-04474-x","journal-title":"Nature"},{"key":"5509_CR102","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai H, Chan FW, Hu B et al (2022) Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 omicron. Nature 603:693\u2013699. https:\/\/doi.org\/10.1038\/s41586-022-04442-5","journal-title":"Nature"},{"key":"5509_CR103","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani DF, Gaebler C, Muecksch F et al (2020) Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584:437\u2013442. https:\/\/doi.org\/10.1038\/s41586-020-2456-9","journal-title":"Nature"},{"issue":"6","key":"5509_CR104","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/infdis\/jiab368","volume":"224","author":"F Isabella","year":"2021","unstructured":"Isabella F, Steven K, Rawlings D et al (2021) SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion. J Infect Dis 224(6):989\u2013994. https:\/\/doi.org\/10.1093\/infdis\/jiab368","journal-title":"J Infect Dis"},{"issue":"7","key":"5509_CR105","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.immuni.2021.06.003","volume":"54","author":"R Wang","year":"2021","unstructured":"Wang R, Zhang Q, Ge J et al (2021) Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity 54(7):1611\u20131621. https:\/\/doi.org\/10.1016\/j.immuni.2021.06.003","journal-title":"Immunity"},{"key":"5509_CR106","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2021.08.036","volume":"574","author":"P Baral","year":"2021","unstructured":"Baral P, Bhattarai N, Hossen L et al (2021) Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 delta variant B.1.617.2 and implications for immune evasion. Biochem Biophys Res Commun 574:14\u201319. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.036","journal-title":"Biochem Biophys Res Commun"},{"issue":"7857","key":"5509_CR107","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang P, Nair MS, Liu L et al (2021) Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593(7857):130\u2013135. https:\/\/doi.org\/10.1038\/s41586-021-03398-2","journal-title":"Nature"},{"key":"5509_CR108","doi-asserted-by":"publisher","first-page":"410","DOI":"10.17179\/excli2020-1167","volume":"19","author":"JT Ortega","year":"2020","unstructured":"Ortega JT, Serrano ML, Pujol FH et al (2020) Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J 19:410\u2013417. https:\/\/doi.org\/10.17179\/excli2020-1167","journal-title":"EXCLI J"},{"issue":"1","key":"5509_CR109","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1038\/s41598-021-86380-2","volume":"11","author":"F Jafary","year":"2021","unstructured":"Jafary F, Jafari S, Ganjalikhany MR (2021) In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Sci Rep 11(1):6927. https:\/\/doi.org\/10.1038\/s41598-021-86380-2","journal-title":"Sci Rep"},{"issue":"4","key":"5509_CR110","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41577-022-00720-5","volume":"22","author":"A Sigal","year":"2022","unstructured":"Sigal A, Milo R, Jassat W (2022) Estimating disease severity of omicron and delta SARS-CoV-2 infections. Nat Rev Immunol 22(4):267\u2013269. https:\/\/doi.org\/10.1038\/s41577-022-00720-5","journal-title":"Nat Rev Immunol"},{"key":"5509_CR111","doi-asserted-by":"publisher","unstructured":"Cong Z, Evans JP, Qu P, et al (2021) Neutralization and stability of SARS-CoV-2 omicron variant. bioRxiv. Preprint at https:\/\/doi.org\/10.1101\/2021.2012.2016.472934.","DOI":"10.1101\/2021.2012.2016.472934"},{"key":"5509_CR112","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","volume":"594","author":"L Braga","year":"2021","unstructured":"Braga L, Ali H, Secco I et al (2021) Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature 594:88\u201393. https:\/\/doi.org\/10.1038\/s41586-021-03491-6","journal-title":"Nature"},{"key":"5509_CR113","doi-asserted-by":"publisher","unstructured":"Edara VV, Manning KE, Ellis M, et al (2022) mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant. Cell Rep. Med. 3(2). https:\/\/doi.org\/10.1016\/j.xcrm.2022.100529.","DOI":"10.1016\/j.xcrm.2022.100529"},{"key":"5509_CR114","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A et al (2021) Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Sci 371:850\u2013854. https:\/\/doi.org\/10.1126\/science.abf9302","journal-title":"Sci"},{"issue":"6583","key":"5509_CR115","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.abn8897","volume":"375","author":"M Mccallum","year":"2021","unstructured":"Mccallum M, Czudnochowski N, Rosen LE et al (2021) Structural basis of SARS-CoV-2 omicron immune evasion and receptor engagement. Sci 375(6583):864\u2013868. https:\/\/doi.org\/10.1126\/science.abn8897","journal-title":"Sci"},{"issue":"7898","key":"5509_CR116","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2021","unstructured":"Liu L, Iketani S, Guo Y et al (2021) Striking antibody evasion manifested by the omicron variant of SARS-CoV-2. Nature 602(7898):676\u2013681. https:\/\/doi.org\/10.1038\/s41586-021-04388-0","journal-title":"Nature"},{"key":"5509_CR117","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-04389-z","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas D, Saunders N, Maes P et al (2021) Considerable escape of SARS-CoV-2 variant omicron to antibody neutralization. Nature 596:276\u2013280. https:\/\/doi.org\/10.1038\/s41586-021-04389-z","journal-title":"Nature"},{"key":"5509_CR118","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu J, Peng P, Cao X et al (2022) Increased immune escape of the new SARS-CoV-2 variant of concern omicron. Cell Mol Immunol 19:293\u2013295. https:\/\/doi.org\/10.1038\/s41423-021-00836-z","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"5509_CR119","doi-asserted-by":"publisher","first-page":"e0144475","DOI":"10.1371\/journal.pone.0144475","volume":"10","author":"J Shi","year":"2015","unstructured":"Shi J, Jing Z, Li S et al (2015) Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases. PLoS ONE 10(12):e0144475. https:\/\/doi.org\/10.1371\/journal.pone.0144475","journal-title":"PLoS ONE"},{"key":"5509_CR120","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/vaccines10091564","volume":"10","author":"SAH Abdi","year":"2022","unstructured":"Abdi SAH, Ali A, Sayed SF et al (2022) Multi-epitope-based vaccine candidate for monkeypox: an in silico approach. Vaccines 10:1564. https:\/\/doi.org\/10.3390\/vaccines10091564","journal-title":"Vaccines"},{"issue":"1","key":"5509_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13721-021-00339-x","volume":"11","author":"A Joshi","year":"2022","unstructured":"Joshi A, Ray NM, Singh J et al (2022) T-cell epitope-based vaccine designing against orthohantavirus: a causative agent of deadly cardio-pulmonary disease. Netw Model Anal Health Inform Bioinforma 11(1):1\u201310. https:\/\/doi.org\/10.1007\/s13721-021-00339-x","journal-title":"Netw Model Anal Health Inform Bioinforma"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-023-05509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-023-05509-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-023-05509-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T14:36:23Z","timestamp":1684852583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-023-05509-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["5509"],"URL":"https:\/\/doi.org\/10.1007\/s00894-023-05509-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2151226\/v1","asserted-by":"object"}]},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"109"}}